Related Experiment Video
Updated: Mar 31, 2026
04:47
A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
Published on: February 23, 2018
8.3K
The Quest for a Universal Flu Vaccine: Headless HA 2.0
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Cell Host & Microbe
|October 16, 2015
Summary
New immunogens targeting the influenza hemagglutinin stalk show promise for universal vaccines. These "headless" constructs induce broad protection in animal models, advancing vaccine development.
Area of Science:
- Virology
- Immunology
- Vaccine Development
Background:
- Influenza virus hemagglutinin (HA) is a key target for vaccines.
- The HA stalk domain contains conserved epitopes recognized by broadly neutralizing antibodies.
- Developing universal influenza vaccines remains a significant challenge.
Purpose of the Study:
- To report the design of novel immunogens based on the influenza virus hemagglutinin stalk domain.
- To evaluate the immunogenicity and protective capacity of these new constructs.
Main Methods:
- Design of "headless" hemagglutinin immunogens lacking the globular head domain.
- Immunization of animal models with the novel immunogens.
- Assessment of antibody responses and protection against heterologous influenza strains.
Main Results:
- The designed immunogens successfully recapitulate conserved epitopes on the HA stalk.
- Immunization induced broadly neutralizing antibodies.
- Animals vaccinated with these constructs exhibited broad/heterosubtypic immunity against influenza challenge.
Conclusions:
- "Headless" hemagglutinin immunogens represent a promising strategy for developing universal influenza vaccines.
- These findings bring the field closer to achieving broad protection against diverse influenza strains.
Related Concept Videos
01:51Vaccinations
53.9K
Overview
53.9K
01:23Vaccine Production
57
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
57
01:21Vaccines
42
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
42
00:42Cross-reactivity
33.8K
Overview
33.8K
01:27Influenza
37
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
37
01:26Human Virome
32
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
32